Avaleht › Kopsuhüpertensioon › Pennsylvania
Kopsuhüpertensioon kliinilised uuringud osariigis Pennsylvania
13 uuringut haiguse Kopsuhüpertensioon jaoks otsivad osalejaid osariigis Pennsylvania.
Linnad osariigis Pennsylvania
Ametlik uuringutekst (inglise keeles)
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- University of Pittsburgh Medical Center, Mechanicsburg
Värbamine
Vanused 18–85 · Kõik sood · Uuendatud 1. okt 2026 · NCT07214376Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA013, Philadelphia
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 29. sept 2026 · NCT07179380Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Thomas Jefferson University, Philadelphia
- Temple University of The Commonwealth System of Higher Education, Philadelphia
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 2. sept 2026 · NCT06911632Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass
- University of Pennsylvania Hospital, Philadelphia
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Kõik sood · Uuendatud 1. sept 2026 · NCT07132788DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- St. Luke's University Health Network, Bethlehem
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University - Sidney Kimmel Medical College, Philadelphia
- ja veel 2
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Kõik sood · Uuendatud 26. aug 2026 · NCT06388421Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
VärbamineFaas 2
Vanused 8–60 · Kõik sood · Uuendatud 14. aug 2026 · NCT03630211A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Temple University, Philadelphia
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 10. aug 2026 · NCT07175038Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Abington Memorial Hospital, Abington
- Penn State Milton S. Hershey Medical Center, Hershey
- University of Pennsylvania, Philadelphia
- ja veel 1
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 10. juuni 2026 · NCT06526195iTONE Trial (exercIse Training in pulmONary hypertEnsion) Exercise Program for Pediatric PH
- Children's Hospital of Philadelphia, Philadelphia
Värbamine
Vanused 8–18 · Kõik sood · Uuendatud 22. apr 2026 · NCT05442671Feasibility of Semaglutide in Advanced Lung Disease
- University of Pennsylvania Perelman School of Medicine, Philadelphia
VärbamineFaas 1/2
Vanused 18–80 · Kõik sood · Uuendatud 21. apr 2026 · NCT05746039PET Image in PAH Patients
- Montefiore Hospital Clinical and Translational Research Center, Pittsburgh
VärbamineVarajane 1. faasTerved vabatahtlikud oodatud
Vanused 18–75 · Kõik sood · Uuendatud 21. jaan 2026 · NCT05452889Pulmonary Hypertension Association Registry
- University of Pennsylvania, Philadelphia
- Allegheny General Hospital, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
VärbamineVaatlusuuring
Vanused 0 ja vanemad · Kõik sood · Uuendatud 14. nov 2025 · NCT04071327Prospective Validation of the Novel PVD-B65 Risk Score in Patients With Chronic Lung Disease and Pulmonary Hypertension
- Temple University Hospital, Philadelphia
VärbamineVaatlusuuring
Vanused 18–99 · Kõik sood · Uuendatud 3. sept 2025 · NCT07151768Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.